{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:07:16Z","timestamp":1769310436011,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Intestinal microinflammation with immune dysfunction due to severe acute respiratory syndrome coronavirus 2 reportedly precipitates post-infectious irritable bowel syndrome. This study aimed to elucidate potential risk factors for subsequent development of irritable bowel syndrome, hypothesizing that it is associated with specific symptoms or patient backgrounds.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This single-center retrospective observational study (2020\u20132021) included adults with confirmed coronavirus disease requiring hospital admission and was conducted using real-world data retrieved from a hospital information system. Patient characteristics and detailed gastrointestinal symptoms were obtained and compared between patients with and without coronavirus disease-induced irritable bowel syndrome. Multivariate logistic models were used to validate the risk of developing irritable bowel syndrome. Moreover, daily gastrointestinal symptoms during hospitalization were examined in patients with irritable bowel syndrome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 571 eligible patients, 12 (2.1%) were diagnosed with irritable bowel syndrome following coronavirus disease. While nausea and diarrhea during hospitalization, elevated white blood cell count on admission, and intensive care unit admission were associated with the development of irritable bowel syndrome, nausea and diarrhea were identified as risk factors for its development following coronavirus disease, as revealed by the adjusted analyses (odds ratio, 4.00 [1.01\u201315.84] and 5.64 [1.21\u201326.31], respectively). Half of the patients with irritable bowel syndrome had both diarrhea and constipation until discharge, and constipation was frequently followed by diarrhea.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>While irritable bowel syndrome was rarely diagnosed following coronavirus disease, nausea and diarrhea during hospitalization precede the early signs of irritable bowel syndrome following coronavirus disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-023-02746-y","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T10:02:43Z","timestamp":1680688963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Early symptoms preceding post-infectious irritable bowel syndrome following COVID-19: a retrospective observational study incorporating daily gastrointestinal symptoms"],"prefix":"10.1186","volume":"23","author":[{"given":"Ryo","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Masaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Keio Donner Project","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Amagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Saya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"2746_CR1","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","volume":"382","author":"PK Bhatraju","year":"2020","unstructured":"Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in critically ill patients in the Seattle region \u2014 case series. N Engl J Med. 2020;382:2012\u201322.","journal-title":"N Engl J Med"},{"key":"2746_CR2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052\u20139.","journal-title":"JAMA"},{"key":"2746_CR3","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"O Abani","year":"2021","unstructured":"Abani O, Abbas A, Abbas F. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY Collaborative Group): A randomised, controlled, open-label, platform trial. Lancet. 2021;397:1637\u201345.","journal-title":"Lancet"},{"key":"2746_CR4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19\u2014Final Report. N Engl J Med. 2020;383:1813\u201326.","journal-title":"N Engl J Med"},{"key":"2746_CR5","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2020.17021","volume":"324","author":"BM Tomazini","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX Randomized Clinical Trial. JAMA. 2020;324:1307\u201316.","journal-title":"JAMA"},{"key":"2746_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00408-021-00423-z","volume":"199","author":"DL Sykes","year":"2021","unstructured":"Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113\u20139.","journal-title":"Lung"},{"key":"2746_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carf\u00ec","year":"2020","unstructured":"Carf\u00ec A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603\u20135.","journal-title":"JAMA"},{"key":"2746_CR8","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMcp2009249","volume":"383","author":"RT Gandhi","year":"2020","unstructured":"Gandhi RT, Lynch JB, Del Rio C. Mild or moderate Covid-19. N Engl J Med. 2020;383:1757\u201366.","journal-title":"N Engl J Med"},{"key":"2746_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395:497\u2013506.","journal-title":"China Lancet"},{"key":"2746_CR10","doi-asserted-by":"publisher","first-page":"e14251","DOI":"10.1111\/nmo.14251","volume":"34","author":"JW Blackett","year":"2022","unstructured":"Blackett JW, Li J, Jodorkovsky D, Freedberg DE. Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19. Neurogastroenterol Motil. 2022;34:e14251.","journal-title":"Neurogastroenterol Motil"},{"key":"2746_CR11","doi-asserted-by":"publisher","first-page":"e00259","DOI":"10.14309\/ctg.0000000000000259","volume":"11","author":"UC Ghoshal","year":"2020","unstructured":"Ghoshal UC, Ghoshal U, Mathur A, Singh RK, Nath A, Garg A, et al. The spectrum of gastrointestinal symptoms in patients with coronavirus Disease-19: predictors, relationship with disease severity, and outcome. Clin Transl Gastroenterol. 2020;11:e00259.","journal-title":"Clin Transl Gastroenterol"},{"key":"2746_CR12","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","volume":"198","author":"F Scialo","year":"2020","unstructured":"Scialo F, Daniele A, Amato F, Pastore L, Matera MG, Cazzola M, et al. ACE2: the major cell entry receptor for SARS-CoV-2. Lung. 2020;198:867\u201377.","journal-title":"Lung"},{"key":"2746_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2018.07.011","volume":"156","author":"G Barbara","year":"2019","unstructured":"Barbara G, Grover M, Bercik P, Corsetti M, Ghoshal UC, Ohman L, et al. Rome foundation working team report on post-infection irritable bowel syndrome. Gastroenterology. 2019;156:46-58.e7.","journal-title":"Gastroenterology"},{"key":"2746_CR14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/ajg.2012.102","volume":"107","author":"B Zanini","year":"2012","unstructured":"Zanini B, Ricci C, Bandera F, Caselani F, Magni A, Laronga AM, et al. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol. 2012;107:891\u20139.","journal-title":"Am J Gastroenterol"},{"key":"2746_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/jgh.15717","volume":"37","author":"UC Ghoshal","year":"2022","unstructured":"Ghoshal UC, Ghoshal U, Rahman MM, Mathur A, Rai S, Akhter M, et al. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study. J Gastroenterol Hepatol. 2022;37:489\u201398.","journal-title":"J Gastroenterol Hepatol"},{"key":"2746_CR16","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.3748\/wjg.v27.i43.7433","volume":"27","author":"CR Settanni","year":"2021","unstructured":"Settanni CR, Ianiro G, Ponziani FR, Bibb\u00f2 S, Segal JP, Cammarota G, et al. COVID-19 as a trigger of irritable bowel syndrome: a review of potential mechanisms. World J Gastroenterol. 2021;27:7433\u201345.","journal-title":"World J Gastroenterol"},{"key":"2746_CR17","doi-asserted-by":"publisher","first-page":"175628482097491","DOI":"10.1177\/1756284820974914","volume":"13","author":"JP Segal","year":"2020","unstructured":"Segal JP, Mak JWY, Mullish BH, Alexander JL, Ng SC, Marchesi JR. The gut microbiome: an under-recognised contributor to the COVID-19 pandemic? Therap Adv Gastroenterol. 2020;13:1756284820974914.","journal-title":"Therap Adv Gastroenterol"},{"key":"2746_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13054-022-03995-1","volume":"26","author":"R Yamamoto","year":"2022","unstructured":"Yamamoto R, Kaito D, Homma K, Endo A, Tagami T, Suzuki M, et al. Early intubation and decreased in-hospital mortality in patients with coronavirus disease 2019. Crit Care. 2022;26:124.","journal-title":"Crit Care"},{"key":"2746_CR19","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920\u20134.","journal-title":"Scand J Gastroenterol"},{"key":"2746_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00535-020-01746-z","volume":"56","author":"S Fukudo","year":"2021","unstructured":"Fukudo S, Okumura T, Inamori M, Okuyama Y, Kanazawa M, Kamiya T, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol. 2021;56:193\u2013217.","journal-title":"J Gastroenterol"},{"issue":"16","key":"2746_CR21","first-page":"00222","volume":"S0016\u20135085","author":"F Mearin","year":"2016","unstructured":"Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016;S0016\u20135085(16):00222\u20135.","journal-title":"Gastroenterology"},{"key":"2746_CR22","doi-asserted-by":"publisher","first-page":"e0176726","DOI":"10.1371\/journal.pone.0176726","volume":"12","author":"A Palaz\u00f3n-Bru","year":"2017","unstructured":"Palaz\u00f3n-Bru A, Folgado-de la Rosa DM, Cort\u00e9s-Castell E, L\u00f3pez-Cascales MT, Gil-Guill\u00e9n VF. Sample size calculation to externally validate scoring systems based on logistic regression models. PLoS ONE. 2017;12:e0176726.","journal-title":"PLoS ONE"},{"key":"2746_CR23","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","volume":"54","author":"EW Steyerberg","year":"2001","unstructured":"Steyerberg EW, Harrell FE Jr, Borsboom GJJM, Eijkemans MJC, Vergouwe Y, Habbema JDF. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54:774\u201381.","journal-title":"J Clin Epidemiol"},{"key":"2746_CR24","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/jmv.25941","volume":"92","author":"X Jiang","year":"2020","unstructured":"Jiang X, Luo M, Zou Z, Wang X, Chen C, Qiu J. Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days. J Med Virol. 2020;92:1807\u20139.","journal-title":"J Med Virol"},{"key":"2746_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abc1669","volume":"369","author":"MM Lamers","year":"2020","unstructured":"Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50\u20134.","journal-title":"Science"},{"key":"2746_CR26","first-page":"3517","volume":"20","author":"T Iacob","year":"2020","unstructured":"Iacob T, \u021a\u0103\u021bulescu DF, Lup\u0219e MS, Dumitra\u0219cu DL. Post-infectious irritable bowel syndrome after a laboratory-proven enteritis. Exp Ther Med. 2020;20:3517\u201322.","journal-title":"Exp Ther Med"},{"key":"2746_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature11228","volume":"487","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487:477\u201381.","journal-title":"Nature"},{"key":"2746_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijid.2020.04.027","volume":"96","author":"H Zhang","year":"2020","unstructured":"Zhang H, Li HB, Lyu JR, Lei XM, Li W, Wu G, et al. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int J Infect Dis. 2020;96:19\u201324.","journal-title":"Int J Infect Dis"},{"key":"2746_CR29","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1017\/S0950268822001200","volume":"150","author":"E Austhof","year":"2022","unstructured":"Austhof E, Bell ML, Riddle MS, Catalfamo C, McFadden C, Cooper K, et al. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT. Epidemiol Infect. 2022;150:e136.","journal-title":"Epidemiol Infect"},{"key":"2746_CR30","doi-asserted-by":"publisher","first-page":"e14187","DOI":"10.1111\/nmo.14187","volume":"34","author":"D Noviello","year":"2022","unstructured":"Noviello D, Costantino A, Muscatello A, Bandera A, Consonni D, Vecchi M, et al. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study. Neurogastroenterol Motil. 2022;34:e14187.","journal-title":"Neurogastroenterol Motil"},{"key":"2746_CR31","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033\u20134.","journal-title":"Lancet"},{"key":"2746_CR32","doi-asserted-by":"publisher","first-page":"110365","DOI":"10.1016\/j.jpsychores.2021.110365","volume":"143","author":"Y Ju","year":"2021","unstructured":"Ju Y, Chen W, Liu J, Yang A, Shu K, Zhou Y, et al. Effects of centralized isolation vs home isolation on psychological distress in patients with COVID-19. J Psychosom Res. 2021;143:110365.","journal-title":"J Psychosom Res"},{"key":"2746_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S2468-1253(16)30023-1","volume":"1","author":"GJ Holtmann","year":"2016","unstructured":"Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2016;1:133\u201346.","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-023-02746-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02746-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T10:07:06Z","timestamp":1680689226000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-023-02746-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2746"],"URL":"https:\/\/doi.org\/10.1186\/s12876-023-02746-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Keio University School of Medicine (application number: 20200063) for conducting research with humans in accordance with the Declaration of Helsinki. Written informed consent was obtained from all the study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}